Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis

Bibliographic Details
Title: Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis
Authors: Joris Guyon, Ignacio Fernandez‐Moncada, Claire M Larrieu, Cyrielle L Bouchez, Antonio C Pagano Zottola, Johanna Galvis, Tiffanie Chouleur, Audrey Burban, Kevin Joseph, Vidhya M Ravi, Heidi Espedal, Gro Vatne Røsland, Boutaina Daher, Aurélien Barre, Benjamin Dartigues, Slim Karkar, Justine Rudewicz, Irati Romero‐Garmendia, Barbara Klink, Konrad Grützmann, Marie‐Alix Derieppe, Thibaut Molinié, Nina Obad, Céline Léon, Giorgio Seano, Hrvoje Miletic, Dieter Henrik Heiland, Giovanni Marsicano, Macha Nikolski, Rolf Bjerkvig, Andreas Bikfalvi, Thomas Daubon
Source: EMBO Molecular Medicine, Vol 14, Iss 12, Pp 1-20 (2022)
Publisher Information: Springer Nature, 2022.
Publication Year: 2022
Collection: LCC:Medicine (General)
LCC:Genetics
Subject Terms: antiepileptic drug, energy metabolism, glioblastoma, invasion, lactate dehydrogenases, Medicine (General), R5-920, Genetics, QH426-470
More Details: Abstract Lactate is a central metabolite in brain physiology but also contributes to tumor development. Glioblastoma (GB) is the most common and malignant primary brain tumor in adults, recognized by angiogenic and invasive growth, in addition to its altered metabolism. We show herein that lactate fuels GB anaplerosis by replenishing the tricarboxylic acid (TCA) cycle in absence of glucose. Lactate dehydrogenases (LDHA and LDHB), which we found spatially expressed in GB tissues, catalyze the interconversion of pyruvate and lactate. However, ablation of both LDH isoforms, but not only one, led to a reduction in tumor growth and an increase in mouse survival. Comparative transcriptomics and metabolomics revealed metabolic rewiring involving high oxidative phosphorylation (OXPHOS) in the LDHA/B KO group which sensitized tumors to cranial irradiation, thus improving mouse survival. When mice were treated with the antiepileptic drug stiripentol, which targets LDH activity, tumor growth decreased. Our findings unveil the complex metabolic network in which both LDHA and LDHB are integrated and show that the combined inhibition of LDHA and LDHB strongly sensitizes GB to therapy.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1757-4676
1757-4684
Relation: https://doaj.org/toc/1757-4676; https://doaj.org/toc/1757-4684
DOI: 10.15252/emmm.202115343
Access URL: https://doaj.org/article/ba568585186d48d99efb5ec52859e399
Accession Number: edsdoj.ba568585186d48d99efb5ec52859e399
Database: Directory of Open Access Journals
More Details
ISSN:17574676
17574684
DOI:10.15252/emmm.202115343
Published in:EMBO Molecular Medicine
Language:English